Another study measured the recruitment of CD4+ cells close to tumor cells in resected metastases following treatment with IFN-α for 0–3 weeks in 26 IFN-treated and 10 untreated patients with regional metastatic melanoma. The gene discussed is CD4; the disease is neoplasm.